Three years had passed since that storm‑lit bungalow morning when Evelyn chose to return to the world—and in that time, technology and compassion had fused into something enduring. The Recursion Chip, once a radical prototype, had become standard care for Empathic Degeneration. Clinics around the globe offered it alongside transplant surgeries, and patient‑led councils steered its ethical use.
**Geneva, Neuro‑Ethics Institute**
Evelyn Larkin moved confidently through the glass‑walled atrium of the Neuro‑Ethics Institute, her ID badge reflecting the midday sun. Lab coats in soft blues and whites passed by—researchers deep in debate, activists planning outreach for low‑income regions. At the foot of a sweeping staircase, Lucien Shen stood chatting with a group of visiting philanthropists.
